Guiding Us to a Better Future, Every Day
Our management team is a talented, diverse, and experienced group of leaders who bring vast expertise across every aspect of our business and operations and a commitment to advance our mission of serving people living with rare diseases and their families.
Management Team
Marc Dunoyer
Chief Executive Officer
Soraya Bekkali
SVP, EUCAN and International Business
Seng Cheng
SVP, Head of Research and Product Development
Fred Chereau
SVP, Strategy & Business Development
Sean Christie
Chief Financial and Administration Officer
Ruth Diazaraque
VP, Research and Development
Shane Doyle
SVP, Head of Operations
Misako Hamamura
VP & General Manager, Japan
Nicola Heffron
SVP, Head of Global Marketing & Market Access
Christophe Hotermans
SVP, Medical Affairs
Simone Lauchart
VP, Project & Portfolio Management
Sarah Marshall
VP, Head of Human Resources
Gianluca Pirozzi
SVP, Head of Development, Regulatory and Safety
Jenny Shum
VP for Global Rare Disease Corporate Affairs
Todd Spalding
SVP, Deputy General Counsel
Scott Weintraub
SVP, United States Business, Alexion